Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OTX-101 (Cequa) Open-Label Extension in Keratoconjunctivitis Sicca
NCT02845674Phase 3Completed
- Sponsor
- Sun Pharma
- Start
- Jul 2016
- Primary completion
- Aug 2017
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of ciclosporin in keratoconjunctivitis sicca (KCS), sponsored by Sun Pharma. Started Jul 2016; status: completed.
02
Drugs
ciclosporin
03
Conditions
keratoconjunctivitis sicca (KCS)
Beyond the preview
Go deeper on NCT02845674.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02845674.